Assistance listing (financial assistance)
Cell and Gene Therapy (CGT) Access Model
Assistance Listing 93.885
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†
† DoD contract data posts to USAspending about 90 days after award.
$5.3M
Federal awards
FY2026 · data still posting
7
Recipients
Assistance Listing 93.885
Code
CFDA 93.885 (Cell and Gene Therapy (CGT) Access Model) accounted for $5.3M in federal grants in FY2026, led by the Department of Health and Human Services, across 7 recipients. Its largest recipient on record was Illinois Department of Healthcare & Family Services, with 24%. FY2026 ended Sep 30 and its data is still posting. Computed
Obligations by year
Computed$4M
FY25
$5.3M
FY26 partial
Key takeaways
Computed- Cell and Gene Therapy (CGT) Access Model (Assistance Listing 93.885) accounted for $5.3M in federal obligations in FY2026, compared with $4M in FY2025.
- The Department of Health and Human Services provided 100% of it.
- Its largest recipient was Illinois Department of Healthcare & Family Services, with 24%.
Top recipients
ComputedThe five largest recipients on record received 81% of this category's FY2026 obligations.
Recipient breakdown available for 88% of obligations shown
Top funding agencies
ComputedRelated
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.